Our mission is to advance DNA sequencing technologies for everyone through innovation.

Universal Sequencing Technology (UST), based in Carlsbad (CA), is an innovative biotechnology company that develops and commercializes disruptive next-generation sequencing (NGS) solutions with a proven track record of success in the genomics space.

Founded in 2015, UST introduced TELL-Seq™ worldwide in 2019 to bring advanced ultra-long-linked-read technology to short read sequencers and researchers everywhere and continues to develop advanced technologies for the genomics industry.

Our proven technology enables short-read sequencers to produce ultra-long-range results (200kb or more) for diploid genomes of virtually any size (microbial, plant, animal, human, etc.) and for applications including de novo sequencing, metagenomics, whole-genome phasing, structural variation detection, phased whole-exome sequencing, and targeted sequencing.

The results are proven to be accurate and require very little DNA input (0.1 – 0.5 ng for bacteria and targeted gene panels, 3 – 5 ng for the human genepanels). A sequencing-ready library can be prepared in 3 hours or less. With a co-marketing and co-development relationship with Illumina signed in 2021, the TELL-Seq™ technology is a valuable tool for genomics research and is commercially available.